Number of shares outstanding for Halozyme Therapeutics (HALO)

Number of shares outstanding as of December 2025 : 117,219,000

According to Halozyme Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 117,219,000. At the end of 2025 the company had 117,219,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Halozyme Therapeutics from 2002 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	0.11 B	-7.27%
2024	0.12 B	-4.21%
2023	0.13 B	-2.45%
2022	0.13 B	-3.52%
2021	0.14 B	3.79%
2020	0.13 B	-4.21%
2019	0.14 B	-2.19%
2018	0.14 B	1.75%
2017	0.14 B	10.56%
2016	0.12 B	0.78%
2015	0.12 B	2.35%
2014	0.12 B	9.44%
2013	0.11 B	1.09%
2012	0.11 B	8.81%
2011	0.10 B	10.26%
2010	93.62 M	4.53%
2009	89.57 M	11.55%
2008	80.29 M	4.96%
2007	76.5 M	21.95%
2006	62.73 M	25.52%
2005	49.97 M	26.29%
2004	39.57 M	382.82%
2003	8.19 M	327.5%
2002	1.91 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
MannKind Corp MNKD	306,806,000	161.74%	🇺🇸 USA
Eli Lilly LLY	895,841,000	664.25%	🇺🇸 USA
Baxter BAX	514,000,000	338.50%	🇺🇸 USA
Pfizer PFE	5,685,000,000	4,749.90%	🇺🇸 USA
Sanofi SNY	2,436,200,000	1,978.33%	🇫🇷 France
Johnson & Johnson JNJ	2,406,195,000	1,952.73%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions